-
Common specific causes of fever in Finnish returned travelers were Campylobacter, malaria, bacteremia, HIV, and influenza; they included a significant proportion of potentially life-threatening infections, and more than one diagnosis. Evaluation of such fevers should be systematic and thorough.
-
The prevalence of Lyme meningitis among children with nonspecific aseptic meningitis occurring from April through December in the years 2006 through 2009 in an endemic area for Lyme disease was 13.3% (95% confidence interval [CI], 6.3%-25.1%).
-
A post-stroke analysis of more than 20,000 patients in 35 countries showed that the lowest risk systolic blood pressure (BP) range is 130-139 mmHg. There is a J-shaped curve of risk with an increase in recurrent stroke among patients with a systolic BP below 120 mmHg and above 140 mmHg.
-
-
Dronedarone was approved by the FDA in the United States for the treatment of patients with atrial fibrillation (AF) several years ago.
-
Recent clinical trials utilizing intravascular ultrasound (IVUS) to quantify coronary artery plaque burden have demonstrated that statin therapy has the potential to arrest the progression of coronary artery disease, and even to effect a small amount of plaque regression.
-
Celivarone is a noniodinated analog of amiodarone that is currently in clinical trials. This report gives us data about the effect of celivarone on ventricular arrhythmias in patients with implantable cardioverter-defibrillators (ICDs).
-
-
New indication for rivaroxaban; new study on warfarin testing; medications causing adverse drug events; niacin as an add-on therapy; and FDA actions.
-
Guidelines recommend aggressive systolic blood pressure (BP) goals (< 130/80 mmHg) in patients at high risk for cardiovascular (CV) events.